Name

SLC19A3 Gene

solute carrier family 19 (thiamine transporter), member 3

This gene encodes a ubiquitously expressed transmembrane thiamine transporter that lacks folate transport activity. Mutations in this gene cause biotin-responsive basal ganglia disease (BBGD); a recessive disorder manifested in childhood that progresses to chronic encephalopathy, dystonia, quadriparesis, and death if untreated. Patients with BBGD have bilateral necrosis in the head of the caudate nucleus and in the putamen. Administration of high doses of biotin in the early progression of the disorder eliminates pathological symptoms while delayed treatment results in residual paraparesis, mild cognitive disability, or dystonia. Administration of thiamine is ineffective in the treatment of this disorder. Experiments have failed to show that this protein can transport biotin. Mutations in this gene also cause a Wernicke's-like encephalopathy.[provided by RefSeq, Jan 2010]

slc19a3 Gene Set

From GeneRIF Biological Term Annotations

genes co-occuring with the biological term slc19a3 in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.

SLC19A3 Gene Set

From Pathway Commons Protein-Protein Interactions

interacting proteins for SLC19A3 from the Pathway Commons Protein-Protein Interactions dataset.

SLC19A3 Gene Set

From LINCS L1000 CMAP CRISPR Knockout Consensus Signatures

genes differentially expressed following the SLC19A3 gene perturbation from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.

SLC19A3 Gene Set

From CM4AI KOLF21J CRISPRi Gene Perturbation Atlas

genes differentially expressed following the SLC19A3 gene perturbation from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas.